Profil
Richard M.
Myers is the founder of SwitchGear Genomics, Inc., founded in 2006, serving as Chairman-Scientific Advisory.
Dr. Myers was the founder of Imidomics, Inc., founded in 2015, serving as Chairman-Science Advisory Board.
Dr. Myers is currently Chief Scientific Officer at The HudsonAlpha Institute for Biotechnology since 2022.
Dr. Myers was Chairman of the Genetics Department at Stanford University.
Postes actifs de Richard M. Myers
| Sociétés | Poste | Début |
|---|---|---|
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology Provides products for studying regulatory elements in the human genome | Fondateur | 01/01/2006 |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology Engages in genomics research and development activities | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Anciens postes connus de Richard M. Myers
| Sociétés | Poste | Fin |
|---|---|---|
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Fondateur | - |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology Provides products for studying regulatory elements in the human genome | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The HudsonAlpha Institute for Biotechnology
The HudsonAlpha Institute for Biotechnology BiotechnologyHealth Technology Engages in genomics research and development activities | Health Technology |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
















